Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331
Abdul-Ghani, Muhammad, Migahid, Osama, Megahed, Ayman, Adams, John, Triplitt, Curtis, DeFronzo, Ralph A., Zirie, Mahmoud, Jayyousi, AminJournal:
Diabetes Care
DOI:
10.2337/dc17-er08d
Date:
June, 2017
File:
PDF, 488 KB
2017